A lawsuit was filed on behalf of investors in Johnson & Johnson (NYSE:JNJ) shares over alleged securities laws violations.
San Diego, CA -- (SBWIRE) -- 02/21/2018 -- The Shareholders Foundation announces that an investor in NYSE:JNJ shares filed a lawsuit over alleged violations of Federal Securities Laws by Johnson & Johnson in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Johnson & Johnson (NYSE:JNJ) should contact the Shareholders Foundation at email@example.com or call +1(858) 779 - 1554.
The plaintiff claims that between February 22, 2013, and February 7, 2018, the defendants made false or misleading statements, and failed to disclose that J&J has known for decades that its talc products include asbestos fibers and that the exposure to those fibers can cause ovarian cancer and mesothelioma. J&J's denials that talc could cause cancer and mesothelioma were materially false and misleading, and the company concealed contingent liabilities and loss of future revenues from the product.
On February 5, 2018,an article was published stating that "court proceedings could expose potentially damaging documents" related to Johnson & Johnson's talc products, such as Johnson's Baby Powder.
On February 7, 2018, the Beasley Allen Law Firm announced that "[l]awsuits filed by ovarian cancer and mesothelioma victims are revealing never-before-seen documents from Johnson & Johnson and talc supplier, Imerys, that shed light on just how prevalent asbestos and heavy metals are in the talc used in Baby Powder." The release stated that "[i]nternal Johnson & Johnson documents from 1972 note that asbestos was found in 100 percent of talc samples tested at the time, but this information was never released publicly." It further stated that Johnson & Johnson stopped funding a project designed to test talc samples for asbestos contamination once a majority of the sample batches were found to be positive for asbestos.
Those who purchased shares of Johnson & Johnson (NYSE:JNJ) have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego
For more information on this press release visit:
Media Relations Contact
Email: Click to Email Michael Daniels